Iridex appoints new president, CEO

Iridex has named David Bruce as its new president and CEO, according to a press release.Bruce, who has been on the company’s board of directors since April 2018, previously served as CEO for several public and private medical device growth-stage compan…

Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025” report has been added to ResearchAndMarkets.com’s offering. Treatment paradigm of eye disorders primarily aims to reduce inflammation, repairs traumatic injuries, and improves or saves eyesight. Treatment comprises of medication, surgery, prescription glasses or contact lenses and treatment of systemic conditions affecting the eye. Prevalence of eye disorders has been increas

VIDEO: Novartis updates product pipeline

VANCOUVER, British Columbia — Dirk Sauer, PhD, Novartis global head of research and development, gives an update on the company’s portfolio, including Luxturna, brolucizumab and a possible presbyopia treatment, at the Association for Research in Vision…